Preeclampsia: Is there value in assessing before clinically evident disease?

Obstetrics and Gynecology

Volumn 98, Issue 4, 2001, Pages 596-599

  Roberts, J M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; HOMOCYSTEINE; LEPTIN; PROSTACYCLIN;

CLINICAL FEATURE; DISEASE MARKER; GROWTH RETARDATION; HUMAN; MATERNAL HYPERTENSION; METABOLISM; OXIDATIVE STRESS; PARITY; PLACENTA DEVELOPMENT; PLASMA VOLUME; POSTNATAL GROWTH; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION;

EID: 0034802853     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(01)01594-0     Document Type: Editorial

References (18)

1. Pathogenesis and genetics of preeclampsia
2. Endothelial dysfunction in preeclampsia
3. Plasma placenta growth factor levels in midtrimester pregnancies
4. First-trimester maternal levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction
5. Preeclampsia disrupts the normal relationship between serum leptin concentrations and adiposity in pregnant women
6. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and preeclampsia
7. Serum homocysteine at 16 weeks and subsequent preeclampsia
8. Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia
9. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of preeclampsia
10. Predictive value of early human chorionic gonadotrophin serum profiles for fetal growth retardation
11. Diagnosis of preeclampsia
12. Cardiovascular function before, during, and after the first and subsequent pregnancies
13. Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis
14. Association of preeclampsia with high birth weight for gestational age
15. Acute atherosis in pregnancies complicated by hypertension, by small-for-gestational age infants, and by diabetes mellitus
16. Maternal placental vasculopathy and infection: Two distinct subgroups among patients with preterm labor and preterm ruptured membranes
17. Polymorphisms in the tumor necrosis factor and lymphotoxin-alpha gene region and preeclampsia
18. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in preeclampsia